Complete Table of Contents 2017

Publication
Article

The table of contents for the latest issue of the journal ONCOLOGY: Perspectives on the Treatment of Hematologic and Solid Malignancies.

August 2017 Table of Contents

Volume 31 | Number 8
REVIEW ARTICLES

Changing Treatment Paradigms for Brain Metastases From Melanoma-Part 1: Diagnosis, Prognosis, Symptom Control, and Local Treatment Vyshak Alva Venur, Pauline Funchain, Rupesh Kotecha, et al

Circulating Tumor DNA as a Liquid Biopsy: Current Clinical Applications and Future DirectionsKimberly M. Komatsubara and Adrian G. Sacher

How an Expert Approaches It

Management of Castration-Resistant, Taxane-Resistant Prostate CancerTomasz M. Beer

Comorbidity Consult

Management of Sleep-Wake Disturbances Comorbid With CancerAnn M. Berger, Ellyn E. Matthews, and Ashley M. Kenkel

Point/Counterpoint

POINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice?Camille Berriochoa, Carisa Bohnak, Nicole Chahine, and Chirag Shah

COUNTERPOINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice?William C. Wood

Q&A

Fay Hlubocky on Recognizing and Addressing Clinician Burnout

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
Despite CD19 CAR T-cell therapy exhibiting efficacy in patients with relapsed/refractory large B-cell lymphoma, less than half achieve long-term remission.
4 experts in this video
4 experts in this video
“Dendritic cell vaccines, CAR T-cell therapy, and things of that nature are holding some promise,” said Andrew Brenner, MD, PhD.
Related Content